Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8314471.
- Also identified by PMC identifier 1374027.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this pilot study of the effects of interferon alfa in 10 anti-HIV positive, chronic hepatitis B patients treated with zidovudine (AZT), tolerance to interferon was good and similar to that in anti-HIV negative patients. After treatment, the HIV stage and CD4 lymphocyte count were unchanged. In two patients hepatitis B virus (HBV)-DNA and hepatitis B e antigen (HBeAg) disappeared and the serum alanine aminotransferase (ALT) returned to normal; loss of hepatitis B surface antigen (HBsAg) with absence of histopathological activity was observed after treatment in one of these patients. These preliminary results need to be confirmed by a larger study.
Medical subject headings
- HIV Seropositivity
- Hepatitis B
- Interferon-alpha
- Zidovudine